Clean Harbors heads into its July 29 Q2 earnings report with the Street increasingly constructive and insider activity telling a subtler story.
The analyst move most worth noting landed on earnings morning itself: Truist Securities raised its target to $350 from $325 today, maintaining a Buy — a rare same-day endorsement that signals conviction ahead of the print. That follows Citigroup lifting its target to $349 earlier this month, also with a Buy rating intact. Barclays sits at the skeptical end, holding Equal-Weight with a $305 target that essentially matches today's close of $305.16. The mean Street target runs at $330, implying modest upside from current levels. The direction of travel across the coverage universe is clearly upward — multiple firms raised targets in the weeks after May's Q1 result — though the bulls and the sideline crowd differ mainly on valuation tolerance, not on whether the business is executing.
The borrow market signals virtually no short-side pressure on CLH. Short interest has crept up 17% over the past month to 2.3% of the free float, a meaningful rate of change but still a low absolute level. More telling is availability, which is extraordinarily loose — over 9,400% relative to shares already borrowed, meaning supply of lendable shares vastly exceeds demand. Cost to borrow has collapsed to just 0.12% after running near 0.50% for most of June and July, reinforcing how little conviction there is on the short side. Options positioning has nudged slightly more defensive, with the put/call ratio at 0.88 versus a 20-day average of 0.75 — about 1.2 standard deviations above trend — but that's a mild caution signal rather than a material hedge. The lending and options picture together read as cautious rather than bearish.
Factor scores corroborate the bull narrative more than the bear one. The 12-month forward EPS growth score ranks in the 88th percentile of the universe, and 30-day EPS momentum sits at the 80th percentile — both pointing to accelerating earnings expectations. The EV/EBITDA multiple has drifted lower by about 0.4 turns over the past month to 13.8x, while the P/E remains near 32.8x. Neither is cheap outright, but both have eased from recent highs. The Benzinga bull case points to raised EBITDA and free cash flow guidance for 2026. The bear case flags weather-related volatility and reliance on specific industrial-recovery cycles — risks that become binary at earnings.
The insider picture adds a nuance. On July 1, essentially the entire senior leadership team — including CEO Eric Gerstenberg, CFO Eric Dugas, and founder and Executive Chairman Alan McKim — sold shares on the same day at $290.74. McKim added another small sale on July 17 at $310. These were modest in dollar terms and scored low on trade significance, likely reflecting scheduled plan activity rather than conviction. But the breadth of sellers on a single date is worth registering ahead of a print that carries some history: Q1 results in May delivered a sharp 10% one-day drop, partially recovered over the following week.
What to watch on July 29 is whether Q2 revenue and EBITDA land in line with the raised 2026 guidance that bullish analysts have already baked into their targets — because with the stock effectively flat on the week and sitting right at Barclays' Equal-Weight target, the margin for a positive surprise to matter is thin, while a miss would revisit the May reaction pattern.
See the live data behind this article on ORTEX.
Open CLH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
